Published in Clin Infect Dis on April 01, 2008
Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev (2012) 4.39
Multidrug resistant acinetobacter. J Glob Infect Dis (2010) 1.94
Activities of colistin- and minocycline-based combinations against extensive drug resistant Acinetobacter baumannii isolates from intensive care unit patients. BMC Infect Dis (2011) 1.33
Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what? Open Biol (2012) 1.24
Influence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia. Antimicrob Agents Chemother (2012) 1.20
High levels of antimicrobial resistance at a tertiary trauma care centre of India. Indian J Med Res (2011) 1.14
Hybrid magnetite nanoparticles/Rosmarinus officinalis essential oil nanobiosystem with antibiofilm activity. Nanoscale Res Lett (2012) 1.05
In vivo and in vitro activity of the siderophore monosulfactam BAL30072 against Acinetobacter baumannii. J Antimicrob Chemother (2011) 0.98
Nosocomial Pseudomonas putida Bacteremia: High Rates of Carbapenem Resistance and Mortality. Chonnam Med J (2012) 0.96
In vitro antibiotic synergy in extensively drug-resistant Acinetobacter baumannii: the effect of testing by time-kill, checkerboard, and Etest methods. Antimicrob Agents Chemother (2010) 0.94
Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates. Eur J Clin Microbiol Infect Dis (2011) 0.93
Nonconcordance with surgical site infection prevention guidelines and rates of surgical site infections for general surgical, neurological, and orthopedic procedures. Antimicrob Agents Chemother (2011) 0.90
Antimicrobial susceptibility of intra-abdominal gram-negative bacilli from Europe: SMART Europe 2008. Eur J Clin Microbiol Infect Dis (2010) 0.90
Characterization, sequencing and comparative genomic analysis of vB_AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolates. BMC Microbiol (2014) 0.89
Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy. BMC Infect Dis (2014) 0.86
One cannot rule them all: Are bacterial toxins-antitoxins druggable? FEMS Microbiol Rev (2015) 0.85
Molecular characterization of beta-lactamase genes and their genetic structures in Acinetobacter genospecies 3 isolates in Taiwan. Antimicrob Agents Chemother (2010) 0.85
Extensively drug-resistant Pseudomonas aeruginosa: risk of bloodstream infection in hospitalized patients. Eur J Clin Microbiol Infect Dis (2012) 0.84
Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa. Sci Rep (2016) 0.83
Multi-drug-resistant gram-negative bacterial infection in surgical patients hospitalized in the ICU: a cohort study. Eur J Clin Microbiol Infect Dis (2011) 0.82
Expression, crystallization and preliminary X-ray crystallographic analysis of alanine racemase from Acinetobacter baumannii OXA-23. Acta Crystallogr Sect F Struct Biol Cryst Commun (2013) 0.81
Antimicrobial Resistance in Pseudomonas sp. Causing Infections in Trauma Patients: A 6 Year Experience from a South Asian Country. J Glob Infect Dis (2014) 0.79
Risk factors and outcomes of infections caused by extremely drug-resistant gram-negative bacilli in patients hospitalized in intensive care units. Am J Infect Control (2014) 0.79
SecA: a potential antimicrobial target. Future Med Chem (2015) 0.79
Infections Caused by Acinetobacter baumannii in Recipients of Hematopoietic Stem Cell Transplantation. Front Oncol (2014) 0.79
A new metric of antibiotic class resistance in gram-negative bacilli isolated from hospitalized children. Infect Control Hosp Epidemiol (2012) 0.78
In vitro antimicrobial susceptibility to isepamicin of 6,296 Enterobacteriaceae clinical isolates collected at a tertiary care university hospital in Greece. Antimicrob Agents Chemother (2012) 0.78
Hydrophilic/hydrophobic characters of antimicrobial peptides derived from animals and their effects on multidrug resistant clinical isolates. Dongwuxue Yanjiu (2015) 0.76
In Vitro activities of combinations of rifampin with other antimicrobials against multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother (2014) 0.76
In Vitro Activity of Delafloxacin against Clinical Neisseria gonorrhoeae Isolates and Selection of Gonococcal Delafloxacin Resistance. Antimicrob Agents Chemother (2016) 0.76
Impact of empirical antimicrobial therapy on the outcome of critically ill patients with Acinetobacter bacteremia. Ann Thorac Med (2015) 0.75
Colistin use in pediatric intensive care unit for severe nosocomial infections: experience of an university hospital. Ann Clin Microbiol Antimicrob (2013) 0.75
In the quest of drugs for bad bugs: are newer fluoroquinolones any better? J Lab Physicians (2011) 0.75
Intravenous Colistin Use for Multidrug-Resistant Gram-Negative Infections in Pediatric Patients. Balkan Med J (2016) 0.75
Susceptibility Pattern and Distribution of Oxacillinases and bla PER-1 Genes among Multidrug Resistant Acinetobacter baumannii in a Teaching Hospital in Iran. J Pathog (2015) 0.75
Outcome of bloodstream infections among spinal cord injury patients and impact of multidrug-resistant organisms. Spinal Cord (2016) 0.75
Successful treatment of a disseminated infection with extensively drug-resistant Klebsiella pneumoniae in a liver transplant recipient with a fosfomycin-based multidrug regimen. Transpl Infect Dis (2016) 0.75
Molecular Study of Acinetobacter baumannii Isolates for Metallo-β-Lactamases and Extended-Spectrum-β-Lactamases Genes in Intensive Care Unit, Mansoura University Hospital, Egypt. Int J Microbiol (2017) 0.75
A step closer to extreme drug resistance (XDR) in gram-negative bacilli. Clin Infect Dis (2007) 3.39
A bibliometric analysis of global research production in respiratory medicine. Chest (2005) 4.15
Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J (2008) 3.60
Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. Crit Care Med (2010) 3.43
Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol (2009) 3.27
Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis (2008) 2.87
Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence. J Antimicrob Chemother (2007) 2.79
Comparison of SCImago journal rank indicator with journal impact factor. FASEB J (2008) 2.77
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis (2010) 2.60
Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med (2007) 2.58
Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Antimicrob Agents Chemother (2005) 2.47
Comparison of amount of biomedical research originating from the European Union and the United States. BMJ (2005) 2.42
Bacterial infection-related morbidity and mortality in cirrhosis. Am J Gastroenterol (2007) 2.35
Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis (2014) 2.29
Adjustment of dosing of antimicrobial agents for bodyweight in adults. Lancet (2009) 2.26
Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome. Anesth Analg (2008) 2.10
β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis (2011) 2.03
Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysis. J Antimicrob Chemother (2012) 2.01
Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies. J Antimicrob Chemother (2008) 1.98
Therapeutic options for infections with Enterobacteriaceae producing carbapenem-hydrolyzing enzymes. Future Microbiol (2011) 1.97
Continuous versus intermittent intravenous administration of antibiotics: a meta-analysis of randomised controlled trials. Lancet Infect Dis (2005) 1.89
Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients. Int J Antimicrob Agents (2009) 1.88
Estimates of global production in cardiovascular diseases research. Int J Cardiol (2005) 1.87
Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: the study, the patient, the bug or the drug? J Infect (2012) 1.84
Epidemiology of constipation in Europe and Oceania: a systematic review. BMC Gastroenterol (2008) 1.77
Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials. PLoS Negl Trop Dis (2008) 1.75
Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials. Clin Infect Dis (2005) 1.74
Unique author identification number in scientific databases: a suggestion. PLoS Med (2006) 1.73
Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study. Crit Care Med (2008) 1.69
Frequency, prevention, outcome and treatment of ventilator-associated tracheobronchitis: systematic review and meta-analysis. Respir Med (2010) 1.67
Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials. Br J Haematol (2005) 1.60
Fluoroquinolones compared with beta-lactam antibiotics for the treatment of acute bacterial sinusitis: a meta-analysis of randomized controlled trials. CMAJ (2008) 1.60
Worldwide prevalence of head lice. Emerg Infect Dis (2008) 1.58
Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis. Crit Care (2005) 1.58
Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence. J Antimicrob Chemother (2008) 1.56
Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens. J Antimicrob Chemother (2011) 1.55
Comparison of first-line with second-line antibiotics for acute exacerbations of chronic bronchitis: a metaanalysis of randomized controlled trials. Chest (2007) 1.55
Impact of patient position on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. J Crit Care (2009) 1.55
Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients. Ann Intensive Care (2011) 1.54
Prevalence of hepatitis B, hepatitis C, and HIV infections among patients in a psychiatric hospital in Greece. Psychiatr Serv (2009) 1.54
Research contribution of different world regions in the top 50 biomedical journals (1995-2002). FASEB J (2006) 1.54
Attributable mortality of Acinetobacter baumannii infection among critically ill patients. Clin Infect Dis (2006) 1.52
Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials. CMAJ (2008) 1.51
Impact of passive humidification on clinical outcomes of mechanically ventilated patients: a meta-analysis of randomized controlled trials. Crit Care Med (2007) 1.50
Effect of thiazolidinedione therapy on restenosis after coronary stent implantation: a meta-analysis of randomized controlled trials. Am Heart J (2007) 1.49
Bowel cleansing before bowel surgery: major discordance between evidence and practice. J Gastrointest Surg (2008) 1.45
Do we still need the aminoglycosides? Int J Antimicrob Agents (2008) 1.45
World databases of summaries of articles in the biomedical fields. Arch Intern Med (2007) 1.43
Effectiveness and safety of short-course vs long-course antibiotic therapy for group a beta hemolytic streptococcal tonsillopharyngitis: a meta-analysis of randomized trials. Mayo Clin Proc (2008) 1.42
Non-physicians may reach correct diagnoses by using Google: a pilot study. Swiss Med Wkly (2008) 1.40
Fluoroquinolones versus beta-lactam based regimens for the treatment of osteomyelitis: a meta-analysis of randomized controlled trials. Spine (Phila Pa 1976) (2008) 1.40
Worldwide trends in quantity and quality of published articles in the field of infectious diseases. BMC Infect Dis (2005) 1.39
From conference abstract to full paper: differences between data presented in conferences and journals. FASEB J (2005) 1.39
Susceptibility of urinary tract bacteria to fosfomycin. Antimicrob Agents Chemother (2009) 1.38
Pain and a purple lesion. Am J Med (2006) 1.38
Tuberculosis of the oral cavity: a systematic review. Eur J Oral Sci (2010) 1.37
The impact of article length on the number of future citations: a bibliometric analysis of general medicine journals. PLoS One (2013) 1.35
Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections. Int J Antimicrob Agents (2009) 1.35
Polymyxin B: similarities to and differences from colistin (polymyxin E). Expert Rev Anti Infect Ther (2007) 1.34
Cure of multidrug-resistant Acinetobacter baumannii bacteraemia with continuous intravenous infusion of colistin. Scand J Infect Dis (2005) 1.33
Age distribution of cases of 2009 (H1N1) pandemic influenza in comparison with seasonal influenza. PLoS One (2011) 1.33
Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence. Int J Antimicrob Agents (2012) 1.32
Human infections associated with wild birds. J Infect (2007) 1.29
Outbreak of OXA-48 carbapenemase-producing Klebsiella pneumoniae in Greece involving an ST11 clone. J Antimicrob Chemother (2012) 1.29
A bibliometric analysis in the fields of preventive medicine, occupational and environmental medicine, epidemiology, and public health. BMC Public Health (2006) 1.27
Mapping health literacy research in the European Union: a bibliometric analysis. PLoS One (2008) 1.25
Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies. Int J Antimicrob Agents (2009) 1.23
Infections related to airway stenting: a systematic review. Respiration (2009) 1.21
Linezolid for the treatment of patients with central nervous system infection. Ann Pharmacother (2007) 1.21
Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis. Intensive Care Med (2011) 1.20
Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials. Mayo Clin Proc (2005) 1.20
Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies. Expert Opin Investig Drugs (2009) 1.19
Probiotics for the prevention of respiratory tract infections: a systematic review. Int J Antimicrob Agents (2009) 1.19
Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials. Ann Allergy Asthma Immunol (2008) 1.18
Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin. Int J Antimicrob Agents (2010) 1.18
Treatment of Acinetobacter infections. Expert Opin Pharmacother (2010) 1.18
Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study. Respir Med (2007) 1.17
Frequency, characteristics, and predictors of microbiologically documented nosocomial infections after cardiac surgery. Eur J Cardiothorac Surg (2006) 1.17
MRSA in Africa: filling the global map of antimicrobial resistance. PLoS One (2013) 1.15
Antiviral treatment for severe EBV infections in apparently immunocompetent patients. J Clin Virol (2010) 1.14
Therapeutic options for Burkholderia cepacia infections beyond co-trimoxazole: a systematic review of the clinical evidence. Int J Antimicrob Agents (2008) 1.13
Outcomes after medical and surgical treatment of diverticulitis: a systematic review of the available evidence. J Gastroenterol Hepatol (2007) 1.12
Do psychological variables affect early surgical recovery? PLoS One (2011) 1.11
Stenotrophomonas maltophilia infections in a general hospital: patient characteristics, antimicrobial susceptibility, and treatment outcome. PLoS One (2012) 1.10
Incidence of postoperative infections in patients undergoing coronary artery bypass grafting surgery receiving antimicrobial prophylaxis with original and generic cefuroxime. J Infect (2007) 1.09
Health literacy research in Europe: a snapshot. Eur J Public Health (2005) 1.08
Insights into infectious disease in the era of Hippocrates. Int J Infect Dis (2008) 1.07
Multidrug-resistant Gram-negative bacterial infections: the emerging threat and potential novel treatment options. Curr Opin Investig Drugs (2008) 1.07
Outcome of antimicrobial therapy in documented biofilm-associated infections: a review of the available clinical evidence. Drugs (2009) 1.07
Meta-analyses on behavioral interventions to reduce the risk of transmission of HIV. Infect Dis Clin North Am (2009) 1.07
World Wide Web resources on control of nosocomial infections. Crit Care (2007) 1.07
Free internal medicine case-based education through the World Wide Web: how, where, and with what? Mayo Clin Proc (2007) 1.06
Colistin and polymyxin B in critical care. Crit Care Clin (2008) 1.06